Test Price
2,800 AED✅ Home Collection Available
FGFR3 Gene Hypochondroplasia NGS Genetic Test in Dubai, UAE | 2,800 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
Executive Summary
This advanced genetic test employs next-generation sequencing (NGS) of the FGFR3 gene to detect pathogenic variants associated with hypochondroplasia and overlapping skeletal dysplasias, delivering diagnostic sensitivity exceeding 99.9% through an ISO 9001:2015 accredited process. The service includes temperature-controlled home sample collection via certified phlebotomy, a post-test telephonic consultation for result interpretation, and direct insurance verification through WhatsApp at +971 54 548 8731.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS processing
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM–11 PM)
- Clinical Guidance: Telephonic post-test counselling for result interpretation and management planning
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
This molecular assay sequences the entire coding region and conserved intronic boundaries of the FGFR3 gene using next-generation sequencing (NGS) with bioinformatic analysis for copy number variants and deep intronic variants. The test provides definitive molecular confirmation of hypochondroplasia and enables differentiation from phenotypically similar skeletal dysplasias, guiding personalised management and family counselling.
| Feature | Our FGFR3 NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | >99.9% analytical sensitivity, full gene coverage including CNV detection | ~95% for targeted exons only; no CNV detection |
| Methodology | NGS with CNV and deep intronic analysis | Sanger sequencing, limited to known mutational hotspots |
| Turnaround Time | 15–21 working days | 3–4 weeks, often delayed due to sequential processing |
Physician Insight & Safety Protocols
Note from Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403): "This FGFR3 NGS test provides definitive molecular confirmation of hypochondroplasia; however, genotype-phenotype correlation with clinical and radiographic assessment remains essential for accurate prognosis. A negative sequencing result does not exclude all genetic aetiologies of disproportionate short stature, and interpretation of novel variants requires specialised expertise in skeletal dysplasias. I strongly recommend pre-test and post-test genetic counselling to guide clinical decision-making."
Medication Advisory
Do not discontinue or modify any prescribed therapy or growth hormone regimen based solely on genetic test results without prior consultation with the referring paediatric endocrinologist or clinical geneticist.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for standalone prenatal diagnosis; chorionic villus sampling or amniocentesis with dedicated prenatal counselling is required.
- Home collection should not be scheduled for patients presenting with acute respiratory compromise or severe skeletal pain necessitating emergency evaluation.
- If new neurological deficits (e.g., limb weakness, severe headache with vomiting) develop following sample collection, immediate emergency assessment is indicated.
- For paediatric patients, written informed consent from a parent or legal guardian is mandatory prior to sample collection, in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the FGFR3 gene hypochondroplasia NGS test, and why is it recommended?
This test analyzes the entire FGFR3 gene to identify pathogenic variants causing hypochondroplasia and related skeletal dysplasias, enabling definitive diagnosis and personalised management. It is recommended when clinical features such as disproportionate short stature, lumbar lordosis, and skeletal radiographic findings suggest a disorder in the FGFR3 spectrum.
2. How is the sample collected, and is home service available across the UAE?
A certified phlebotomist collects a peripheral blood sample at your home using a temperature-controlled kit to ensure nucleic acid integrity for NGS analysis. VIP mobile phlebotomy is available daily from 8 AM to 11 PM, with cold-chain transport to our ISO-accredited laboratory.
3. Will my insurance cover the cost of this genetic test?
Many UAE health insurers cover medically necessary genetic testing when ordered by a physician. Our team verifies your policy directly via WhatsApp before scheduling, ensuring clarity on coverage and any applicable co-payment.
4. How long does it take to receive results, and how will they be communicated?
The turnaround time is 15 to 21 working days. Results are delivered via a secure digital report and explained during a telephonic consultation with a genetic specialist to guide clinical follow-up.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for the secure processing of genetic data, Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for digital health information governance, and Federal Decree-Law No. 4 of 2016 on Medical Liability governing clinical safety and patient consent. All laboratory procedures are performed under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | FGFR3 Gene Hypochondroplasia NGS Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 15–21 working days |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or buccal swab; VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily 8 AM–11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV and deep intronic analysis |
| ICD-10-CM Code | Q77.4 |
| LOINC Code | 91846-2 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians